IL6 and hyperlipidemia: This showed that XOS increased the level of anti-inflammatory factor IL-10 and reduced the levels of pro-inflammatory factors TNF-α, IFN-γ, and IL-6 in the serum, thus exerting a regulatory effect on the blood lipid levels of mice with hyperlipidemia.